Literature DB >> 2757919

Microscopic distribution of misonidazole in mouse tissues.

L M Cobb1, J Nolan, P O'Neill.   

Abstract

Mice were injected with tritiated misonidazole (750 mg/kg-1), killed after 24h and the excised tissues prepared for autoradiography (ARG) to identify sites of accumulation. The previously reported high grain count associated with bound misonidazole metabolite(s) was observed in the liver. The ratio of grain count in the emulsion above the centrilobular hepatocytes to the count over connective tissue (stroma) was 12. A higher count ratio for 'target' cells to stroma was observed in the following cells/tissues: meibomian gland (ducts 110, acini 65), oesophagus (keratinised layer 60), incisor (enamel organ 17), nasal septum (subepithelial glands 13). For some of these tissues the explanation might appear to lie with localised hypoxia, but for others which were probably normoxic there is as yet no obvious reason for these findings.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757919      PMCID: PMC2246964          DOI: 10.1038/bjc.1989.4

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice.

Authors:  J B Chin; A M Rauth
Journal:  Radiat Res       Date:  1981-05       Impact factor: 2.841

2.  Pharmacology and toxicology of sensitizers: mechanism studies.

Authors:  A M Rauth
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-08       Impact factor: 7.038

3.  Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites.

Authors:  A J Franko; C J Koch
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-08       Impact factor: 7.038

4.  The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.

Authors:  B M Garrecht; J D Chapman
Journal:  Br J Radiol       Date:  1983-10       Impact factor: 3.039

5.  Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.

Authors:  M E McManus; A Monks; J M Collins; R White; J M Strong
Journal:  J Pharmacol Exp Ther       Date:  1981-12       Impact factor: 4.030

6.  Pharmacokinetics of hypoxic cell radiosensitizers: a review.

Authors:  P Workman
Journal:  Cancer Clin Trials       Date:  1980

7.  Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.

Authors:  J S Rasey; Z Grunbaum; K Krohn; N Nelson; L Chin
Journal:  Radiat Res       Date:  1985-03       Impact factor: 2.841

8.  Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.

Authors:  J D Chapman; K Baer; J Lee
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

9.  Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.

Authors:  J A Raleigh; A J Franko; C J Koch; J L Born
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

10.  The penetration of misonidazole into a mature structural cartilage.

Authors:  A J Langler; R D Bugden; P Gibson
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

View more
  7 in total

1.  Hypoxia: A breath of fresh air for the meibomian gland.

Authors:  Yang Liu; Di Chen; Xiaomin Chen; Wendy R Kam; Mark P Hatton; David A Sullivan
Journal:  Ocul Surf       Date:  2018-12-04       Impact factor: 5.033

2.  Analysis of a Nitroreductase-Based Hypoxia Sensor in Primary Neuronal Cultures.

Authors:  Britney N Lizama-Manibusan; Sharon Klein; Jennifer R McKenzie; David E Cliffel; BethAnn McLaughlin
Journal:  ACS Chem Neurosci       Date:  2016-08-24       Impact factor: 4.418

3.  Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.

Authors:  Quynh-Thu X Le; James Moon; Mary Redman; Stephen K Williamson; Primo N Lara; Zelanna Goldberg; Laurie E Gaspar; John J Crowley; Dennis F Moore; David R Gandara
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

4.  NAD(P)H nitroblue tetrazolium reductase levels in apparently normoxic tissues: a histochemical study correlating enzyme activity with binding of radiolabelled misonidazole.

Authors:  L M Cobb; T Hacker; J Nolan
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

5.  Distribution of pimonidazole and RSU 1069 in tumour and normal tissues.

Authors:  L M Cobb; J Nolan; S A Butler
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

6.  Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.

Authors:  M B Parliament; L I Wiebe; A J Franko
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

7.  Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity.

Authors:  C J Koch; S M Evans; E M Lord
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.